Biotechnology Jobs

• Zug, Switzerland
• On-site
• US$222,750 – US$371,250 pa
• Director

Serves as the physician within oncology clinical programme teams for lung and head/neck cancers, leading medical monitoring, safety oversight and clinical data interpretation. Partners with the Senior Scientist and cross-functional teams on protocol development, regulatory interactions and investigator engagement, with on-site presence 2-3 days per week.

AI-enabled insights

• London
• On-site
• US$222,750 – US$371,250 pa
• Director

Serves as the physician within oncology clinical programme teams for lung and head/neck cancers, leading medical monitoring, safety oversight and clinical data interpretation across Phase I–III studies. Partners with Senior Scientists and cross-functional matrix teams on protocol development, regulatory interactions and investigator engagement, with on-site presence 2–3 days per week.

AI

• London
• Hybrid · 2 days in office
• £123,000 – £205,000 pa
• Director · manages people

Leads respiratory epidemiology and real-world evidence programmes that inform vaccine development, designing and overseeing complex studies on disease burden, treatment patterns and safety. Partners with clinical development, safety, regulatory and external collaborators, and mentors junior staff. Requires deep RWE and pharmaco-epidemiology expertise in a global, matrixed environment.

• Belgium-Wavre
• Hybrid · 2 days in office
• €123,000 – €205,000 pa
• Director · manages people

Leads respiratory epidemiology and real-world evidence programs that inform vaccine development, owning the epidemiology plan for at least one asset or disease area. Designs and oversees complex observational studies using claims, EHR and registry data, advises clinical, safety and regulatory teams, and manages external partnerships while mentoring junior scientists.

Electronic Health Records · Claims Data · Registries

• Waltham, United States
• Hybrid · 2–3 days in office
• Director · manages people

Leads end-to-end clinical development of hematology oncology assets from first-in-human studies through registrational trials, regulatory approval and launch. Sets disease-area strategy, chairs governance forums and scientific advisory boards, and line-manages clinical development leads and medical directors within a global matrix team.

AI/ML

• Stevenage
• Hybrid · 2–3 days in office
• Director · manages people

Leads end-to-end clinical development of hematology oncology assets from first-in-human studies through registrational trials, regulatory approval and launch. Provides portfolio oversight, chairs governance forums and scientific advisory boards, and line-manages Clinical Development Leads and Medical Directors within a global matrix team.

AI/ML

• London
• Hybrid · 2–3 days in office
• Director · manages people

Leads end-to-end clinical development strategy for a hematology oncology portfolio, from first-in-human studies through registrational trials, regulatory approval and initial launch. Provides program oversight at governance forums, co-leads asset development with matrix partners, and line-manages Clinical Development Leads, Medical Directors and Clinical Scientists. Champions novel approaches such as AI/ML, innovative trial designs and real-world data.

AI/ML

• Upper Providence
• Hybrid · 2–3 days in office
• Director · manages people

Leads end-to-end clinical development of hematology oncology assets from first-in-human studies through registrational trials, approval and launch. Sets disease-area strategy, chairs governance forums and advisory boards, and line-manages clinical development leads within a global matrix. Distinct for its portfolio-level enterprise scope and hybrid US/UK/Swiss base.

AI/ML

• Baar Onyx
• Hybrid · 2–3 days in office
• Director · manages people

Leads end-to-end clinical development of hematology oncology assets from first-in-human studies through registrational trials, regulatory approval and initial launch. Chairs governance forums, co-leads matrix asset teams and line-manages clinical development leads, medical directors and clinical scientists. Distinct for its portfolio-level scope across early- and late-phase programs and its cross-functional connector role spanning research, translational medicine and commercial strategy.

AI/ML

• Durham
• Hybrid · 2–3 days in office
• €87,000 – €145,000 pa
• Director

Provides medical and scientific expertise in safety evaluation and risk management for GSK assets across clinical development and post-marketing settings. Leads signal detection, regulatory periodic reports, and benefit-risk assessments while collaborating with cross-functional teams including Clinical Operations, Regulatory, and Biostatistics. Involves presenting complex safety issues to senior governance committees and contributing to global regulatory submissions.

ICH · GVP · CIOMS

• Greater Poland
• Hybrid · 2–3 days in office
• €87,000 – €145,000 pa
• Director
• Permanent

Provides medical and scientific expertise in safety evaluation and risk management for GSK assets across clinical development and post-marketing settings. Leads signal detection, benefit-risk assessment, regulatory periodic reports and RMPs, working within a global cross-functional matrix alongside Clinical Operations, Regulatory and Biostatistics. Distinct for its strong focus on pharmacovigilance governance, safety strategy and scientific writing.

ICH · GVP · CIOMS

• London
• Hybrid · 2–3 days in office
• €87,000 – €145,000 pa
• Director
• Permanent

Provides medical and scientific expertise in safety evaluation and risk management for GSK assets across clinical development and post-marketing settings. Leads signal detection, periodic regulatory reports, RMPs and benefit-risk assessments within a global cross-functional matrix, presenting complex safety issues to senior governance committees. Distinct for its blend of pharmacovigilance strategy, regulatory writing and matrix leadership.

ICH · GVP · CIOMS

• Belgium-Wavre
• Hybrid · 2–3 days in office
• €87,000 – €145,000 pa
• Director
• Permanent

Provides medical and scientific expertise in safety evaluation and risk management for GSK assets across clinical development and post-marketing settings. Leads signal detection, benefit-risk assessment, regulatory periodic reports and RMPs, and contributes to safety strategy within a global cross-functional matrix. Involves presenting complex safety issues to senior governance committees and mentoring matrix colleagues.

ICH · GVP · CIOMS

• London
• Hybrid
• PLN 318,000 – PLN 530,000 pa
• Director

Supports patient safety worldwide by leading signal detection, safety evaluation and risk management for products in clinical development and post-marketing. Prepares global regulatory reports and risk management plans, supports safety governance meetings, and contributes to risk-reduction strategies across cross-functional matrix teams.

Safety Databases · Data Visualisation Tools

• Warsaw, Poland
• Hybrid
• PLN 318,000 – PLN 530,000 pa
• Director

Leads signal detection and evaluation for assigned products, prepares global regulatory reports and risk management plans, and supports safety governance meetings across clinical and post-marketing settings. Works in cross-functional matrix teams, contributes to risk-reduction strategies, and mentors colleagues while driving process improvements in pharmacovigilance.

Safety Databases · Data Visualisation Tools